All News

For busy clinicians, new technologies promise savings in time as well as costs?in theory. But in practice, is this actually true? The jury is still out.

Statin drugs may lessen the risk for return of prostate cancer in individuals who have undergone radical prostatectomy.

Most biochemical recurrence of prostate cancer following radical prostatectomy occurs within 10 years, and patients who remain free from progression a decade postoperatively can be counseled that their risk of subsequent cancer-related morbidity and mortality is low.

A mandatory second opinion to interpret prostate needle biopsy prior to radical prostatectomy in a few cases results in differences that may affect therapy.

Bacillus Calmette-Guérin (has been the standard of care for bladder cancer for nearly 40 years. Little is known about BCG or its mechanism of action, however. A trial currently under way at M.D. Anderson Cancer Center, Houston, may help urologists to separate responders from nonresponders early and tailor therapy for optimal results in those who respond to the drug.

Occupational exposures in painters are associated with an elevated risk for bladder cancer, a risk that increases with years on the job.

New urology products and services from sanofi-aventis, American Medical Systems, Karl Storz Endoscopy-America, Inc., Ethicon Endo-Surgery, Cook Medical, and GE Healthcare.

A robot-assisted laparoscopic approach to partial nephrectomy maintains oncologic principles and renal function while offering several benefits compared with a conventional laparoscopic technique.

High-intensity focused ultrasound as primary therapy for localized prostate cancer can produce outcomes that equal external beam radiation therapy.

Possible new federal self-referral restrictions on radiation therapy services are being aggressively challenged by a nationwide group of integrated group practice physicians who take issue with charges that physician ownership of equipment used in the procedures results in increased and unnecessary services and Medicare costs.

Testicular cancer patients who are exposed to radiotherapy have a greater risk of being diagnosed with a subsequent non-testicular cancer, including bladder cancer.

Among studies on high-intensity focused ultrasound presented at the AUA annual meeting in San Francisco, two showed encouraging biochemical disease-free survival rates for primary treatment as well as salvage therapy.

Preliminary results from a phase III trial do not support the research hypothesis that the addition of bevacizumab (Avastin) to a regimen combining docetaxel (Taxotere) and prednisone improves survival in patients with metastatic castration-resistant prostate cancer.

Internet-based information on robotic cystectomy, much of it provided by surgeons, often overstates claims and outcomes compared to what can be supported by evidence.

The average U.S. citizen is living longer primarily because of advancements in medical care. This means a higher likelihood of needing long-term care.

The mainstay of care for men with locally advanced prostate cancer has been hormonal therapy alone, but data from a recent randomized, controlled trial comparing hormonal therapy alone with radiation added to hormonal therapy should challenge this dogma.

Men with prostate cancer who undergo robot-assisted radical prostatectomy achieve equivalent urinary and sexual function outcomes relative to their counterparts managed with open surgery.

A urology journal's impact factor may not always represent the best way to capture a publication's value and influence.

How do you plan cash flow with more delays and/or significant reductions looming for Medicare?

Complications after urinary diversion occur often and continue to occur for at least 5 years after surgery.

Although some urologists are intrigued by what the future may hold for immunotherapy, many aren't sure if sipuleucel-T is the treatment that will transform their approach to prostate cancer.

Cigarette smoking is associated with more advanced prostate tumors among men undergoing radical prostatectomy, but there appears to be little difference between smokers and non-smokers when it comes to biochemical recurrence.

The owners of most medical practices feel confident in the service they provide and believe they are both meeting their patients' needs and making a good first impression. But are they? Taking a critical look at the average practice, I'm not so sure.

Urologists share how EMRs, recycling and reducing waste help make their practices reduce their environmental impact.

When an official acting on behalf of a government agency contacts a medical practice, it can be a daunting, even frightening experience-one that requires knowledge of your rights and what you must and should do.

In men with bone metastasis from castration-resistant prostate cancer, a monthly subcutaneous injection with denosumab, 120 mg, is superior to monthly intravenous zoledronic acid (Zometa), 4 mg, for preventing and delaying first on-study and multiple skeletal-related events.

Interim results from a long-term study of active and former chemical industry workers suggest that tumor markers in urine may emerge as a practical and reliable noninvasive diagnostic for bladder cancer.

Urologists using flexible cystoscopy with narrow-band imaging find more new nonmuscle-invasive bladder cancers than with flexible cystoscopy using white light.

Datta Wagle, MD, newly appointed 2010-'11 AUA president, discusses current initiatives taking shape at the AUA and the AUA Foundation, as well as his goals and priorities as AUA president.

Irreversible electroporation appears to be a promising nonthermal technique for renal tissue ablation.